Literature DB >> 14659144

Systematic review of fibroadenoma as a risk factor for breast cancer.

H El-Wakeel1, H C Umpleby.   

Abstract

Fibroadenoma (FA) is a common breast lesion occurring in 25% of asymptomatic women. Several studies considered FA as a risk factor for breast cancer, prompting a systematic review of the literature. We selected cohort and case-control studies. Seven studies satisfied the selection criteria. Dupont et al. (1994) and McDivitt et al. (1992) were considered to provide the strongest evidence, showing the relative risk for excised FA without hyperplasia in the range 1.48-1.7, with hyperplasia 3.47-3.7, and with hyperplasia and atypia 6.9-7.29, persisting for more than 20 years. Five studies by Levi et al. (1994), Ciatto et al. (1997), Moskowitz et al. (1980), Carter et al. (1988), and Levshin et al. (1998), were considered to provide weaker evidence, although they showed similar results. None of the results could be used to quantify the risks of excised, non-excised, and asymptomatic FA. More care should be taken in managing patients with complex FAs and FAs with hyperplasia with or without atypia. Core biopsy may be a better option in diagnosis of FAs. Regular screening may be advisable in patients with FAs and a family history of breast cancer in a first-degree relative. More rigorous research is needed in this area.

Entities:  

Mesh:

Year:  2003        PMID: 14659144     DOI: 10.1016/s0960-9776(03)00123-1

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  20 in total

Review 1.  Benign Breast Disease in Women.

Authors:  Angrit Stachs; Johannes Stubert; Toralf Reimer; Steffi Hartmann
Journal:  Dtsch Arztebl Int       Date:  2019-08-09       Impact factor: 5.594

2.  4-Vinylcyclohexene diepoxide (VCD) inhibits mammary epithelial differentiation and induces fibroadenoma formation in female Sprague Dawley rats.

Authors:  Laura E Wright; Jennifer B Frye; Ashley L Lukefahr; Samuel L Marion; Patricia B Hoyer; David G Besselsen; Janet L Funk
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

3.  Messenger RNA of the Histidine-Rich Glycoprotein in Breast Tumors.

Authors:  A I Autenshlyus; I I Brusentsov; I O Marinkin; S A Smirnova; M Yu Rukavishnikov; V V Lyakhovich
Journal:  Dokl Biochem Biophys       Date:  2018-03-14       Impact factor: 0.788

4.  History of benign breast disease and risk of breast cancer among women in China: a case-control study.

Authors:  Tsogzolmaa Dorjgochoo; Sandra L Deming; Yu-Tang Gao; Wei Lu; Ying Zheng; Zhixian Ruan; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2008-03-18       Impact factor: 2.506

5.  Diagnosis and management of fibroadenomas in the adolescent breast.

Authors:  Felecia Cerrato; Brian I Labow
Journal:  Semin Plast Surg       Date:  2013-02       Impact factor: 2.314

6.  Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study.

Authors:  Aziza Nassar; Daniel W Visscher; Amy C Degnim; Ryan D Frank; Robert A Vierkant; Marlene Frost; Derek C Radisky; Celine M Vachon; Ruth A Kraft; Lynn C Hartmann; Karthik Ghosh
Journal:  Breast Cancer Res Treat       Date:  2015-08-12       Impact factor: 4.872

7.  Progesterone receptors A and B and estrogen receptor alpha expression in normal breast tissue and fibroadenomas.

Authors:  Gisele Branchini; Lolita Schneider; Rodrigo Cericatto; Edison Capp; Ilma Simoni Brum
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

8.  A clinico-pathological study on benign breast diseases.

Authors:  Mima B Maychet Sangma; Kishori Panda; Simon Dasiah
Journal:  J Clin Diagn Res       Date:  2013-01-10

9.  Juvenile fibroadenoma of the breast: Treatment and literature review.

Authors:  Wendy K Ng; M Amir Mrad; Mitchell H Brown
Journal:  Can J Plast Surg       Date:  2011

10.  Clinical features and pattern of presentation of breast diseases in surgical outpatient clinic of a suburban tertiary hospital in South-west Nigeria.

Authors:  Babatunde A Ayoade; Adedayo O Tade; Babatunde A Salami
Journal:  Niger J Surg       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.